ArticleNeuro-oncology2018

Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas.

Ovidiu C AndronesiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.